Motor neuron diseases (MNDs) include a broad group of diseases in which neurodegeneration mainly affects upper and/or lower motor neurons (MNs). Although the involvement of specific MNs, symptoms, age of onset, and progression differ in MNDs, the main pathogenic mechanism common to most MNDs is represented by proteostasis alteration and proteotoxicity. This pathomechanism may be directly related to mutations in genes encoding proteins involved in the protein quality control system, particularly the autophagy-lysosomal pathway (ALP). Alternatively, proteostasis alteration can be caused by aberrant proteins that tend to misfold and to aggregate, two related processes that, over time, cannot be properly handled by the ALP. Here, we summarize the main ALP features, focusing on different routes utilized to deliver substrates to the lysosome and how the various ALP pathways intersect with the intracellular trafficking of membranes and vesicles. Next, we provide an overview of the mutated genes that have been found associated with MNDs, how these gene products are involved in different steps of ALP and related processes. Finally, we discuss how autophagy can be considered a valid therapeutic target for MNDs treatment focusing on traditional autophagy modulators and on emerging approaches to overcome their limitations.

The role of autophagy-lysosomal pathway in motor neuron diseases / B. Tedesco, V. Ferrari, M. Cozzi, M. Chierichetti, E. Casarotto, P. Pramaggiore, F. Mina, M. Piccolella, R. Cristofani, V. Crippa, P. Rusmini, M. Galbiati, A. Poletti. - In: BIOCHEMICAL SOCIETY TRANSACTIONS. - ISSN 0300-5127. - 50:5(2022 Oct), pp. 1489-1503. [10.1042/BST20220778]

The role of autophagy-lysosomal pathway in motor neuron diseases

B. Tedesco
Co-primo
;
V. Ferrari
Co-primo
;
M. Cozzi;M. Chierichetti;E. Casarotto;P. Pramaggiore;F. Mina;M. Piccolella;R. Cristofani;V. Crippa;P. Rusmini;M. Galbiati
Penultimo
;
A. Poletti
Ultimo
2022

Abstract

Motor neuron diseases (MNDs) include a broad group of diseases in which neurodegeneration mainly affects upper and/or lower motor neurons (MNs). Although the involvement of specific MNs, symptoms, age of onset, and progression differ in MNDs, the main pathogenic mechanism common to most MNDs is represented by proteostasis alteration and proteotoxicity. This pathomechanism may be directly related to mutations in genes encoding proteins involved in the protein quality control system, particularly the autophagy-lysosomal pathway (ALP). Alternatively, proteostasis alteration can be caused by aberrant proteins that tend to misfold and to aggregate, two related processes that, over time, cannot be properly handled by the ALP. Here, we summarize the main ALP features, focusing on different routes utilized to deliver substrates to the lysosome and how the various ALP pathways intersect with the intracellular trafficking of membranes and vesicles. Next, we provide an overview of the mutated genes that have been found associated with MNDs, how these gene products are involved in different steps of ALP and related processes. Finally, we discuss how autophagy can be considered a valid therapeutic target for MNDs treatment focusing on traditional autophagy modulators and on emerging approaches to overcome their limitations.
HSPB8; ALS; SBMA; Kennedy’s disease; androgen; motoneuron diseases; chaperone; proteasome; autophagy; aggregation; misfolding; casa
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
CAR_RIC15APOLE_M - RAN translation of normal and expanded nucleotide repeat containing transcripts to neurotoxic polypetides in neurodegenerative diseases - POLETTI, ANGELO - CAR_RIC - Bandi Fondazione Cariplo - 2015
INTLI19RCRIS_01 - Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease - CRISTOFANI, RICCARDO MARIA - INTLI - Finanziamenti internazionali - 2019
FON_NAZ19APOLE_03 - Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
INTLI21MGALB_01 - Unveiling regenerative and metabolic features of SBMA muscle cells to identify new therapeutic targets - GALBIATI, MARIARITA - INTLI - Finanziamenti internazionali - 2021
INTLI21APOLE_01 - The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis - POLETTI, ANGELO - INTLI - Finanziamenti internazionali - 2021
FON_NAZ19APOLE_02 - Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS) - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
AL_RIC18APOLE_01 - Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS) - POLETTI, ANGELO - AL_RIC - Bandi da altri enti di ricerca - 2018
PRIN201719APOLE_01 - The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS) - POLETTI, ANGELO - PRIN2017 - PRIN bando 2017 - 2019
PRIN202022VCRIP_01 - Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models - CRIPPA, VALERIA - PRIN2020 - PRIN bando 2020 - 2022
CAR_RIC22RCRIS_01 - Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases - CRISTOFANI, RICCARDO MARIA - CAR_RIC - Bandi Fondazione Cariplo - 2022
16-set-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
bst-2022-0778c.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.6 MB
Formato Adobe PDF
2.6 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/938047
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact